Levetiracetam
Product Images NDC 50090-5495

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-5495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905495)

This is a medication with the name Levitiracetam with a dosage of 1600 mg. The medication comes in a pack of 30 tablets and should be stored at a temperature of 68-107 degrees.*

FDA Label Image

Levetiracitam Tablets, Usp-figure07 (Levetiracetam Tablets Usp 1)

This appears to be a formula for estimating the estimated glomerular filtration rate (eGFR) of female patients based on their age, weight, and serum creatinine level. The formula involves calculating CLer, which is then adjusted for body surface area. The given text seems to be incomplete as important context and units are missing.*

FDA Label Image

9596f2fe-figure-01 (Levetiracetam Tablets Usp 2)

FDA Label Image

20 (Levetiracetam Tablets Usp 3)

This text represents a clinical trial comparing the effectiveness of the medication Levetiracetam with a placebo in treating a certain condition. The trial includes 95 participants in the placebo group and 97 and 101 participants in two different dosages of Levetiracetam groups.*

FDA Label Image

14 (Levetiracetam Tablets Usp 4)

FDA Label Image

Levetiracetam Tablets Usp 5

This appears to be a set data results or statistics, with some percentages and medical terms, including two groups (a Placebo group and a Levetiracetam group) mentioned with their corresponding sample sizes. However, without additional context or explanation, it is difficult to provide a specific description or interpretation of this data.*

FDA Label Image

54 (Levetiracetam Tablets Usp 6)

The given text displays some percentages and patient counts for placebo and a medication called "Levetiracetam." However, no context or further information is available, so it's not possible to give a meaningful description with the given text.*

FDA Label Image

78 (Levetiracetam Tablets Usp 7)

The text provides the percentage of patients in two groups - 43.1% in an unspecified group and 19.6% in another. The data is then compared to a placebo group consisting of 51 people. The text indicates that the Levetiracetam group consisting of 58 people was statistically significant compared to the placebo group.*

FDA Label Image

10 (Levetiracetam Tablets Usp 8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.